What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
His main research concerns Internal medicine, Surgery, Ulcerative colitis, Crohn's disease and Inflammatory bowel disease.
His research brings together the fields of Gastroenterology and Internal medicine.
He combines subjects such as Adverse effect, Infliximab, Incidence and Cohort study with his study of Surgery.
His studies deal with areas such as Ileitis, Rochester Epidemiology Project and Confidence interval as well as Ulcerative colitis.
His Crohn's disease research is multidisciplinary, incorporating perspectives in Immunology, Meta-analysis, Radiology, Colonoscopy and Cohort.
His research in Inflammatory bowel disease tackles topics such as Relative risk which are related to areas like Absolute risk reduction.
His most cited work include:
- Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences (2399 citations)
- Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology (2220 citations)
- The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study (934 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Gastroenterology, Inflammatory bowel disease, Ulcerative colitis and Crohn's disease.
Edward V. Loftus frequently studies issues relating to Surgery and Internal medicine.
His study looks at the relationship between Gastroenterology and fields such as Primary sclerosing cholangitis, as well as how they intersect with chemical problems.
The concepts of his Inflammatory bowel disease study are interwoven with issues in Odds ratio and Immunology.
His biological study spans a wide range of topics, including Adverse effect, Infliximab, Colitis and Cohort.
While the research belongs to areas of Crohn's disease, Edward V. Loftus spends his time largely on the problem of Incidence, intersecting his research to questions surrounding Epidemiology.
He most often published in these fields:
- Internal medicine (70.01%)
- Gastroenterology (40.76%)
- Inflammatory bowel disease (35.27%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (70.01%)
- Ulcerative colitis (33.37%)
- Inflammatory bowel disease (35.27%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Ulcerative colitis, Inflammatory bowel disease, Gastroenterology and Crohn's disease.
Edward V. Loftus conducts interdisciplinary study in the fields of Internal medicine and In patient through his research.
His work is dedicated to discovering how Ulcerative colitis, Tofacitinib are connected with Open label and other disciplines.
His research investigates the connection between Inflammatory bowel disease and topics such as Proportional hazards model that intersect with issues in Hazard ratio.
His Gastroenterology research integrates issues from Infliximab, Placebo, Primary sclerosing cholangitis, Antibody and Induction therapy.
His Crohn's disease research incorporates elements of Surgery, Abdominal surgery, Incidence and Ustekinumab.
Between 2017 and 2021, his most popular works were:
- ACG Clinical Guideline: Management of Crohn’s Disease in Adults (310 citations)
- Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis (132 citations)
- Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting. (94 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
His primary areas of study are Internal medicine, Crohn's disease, Inflammatory bowel disease, Ulcerative colitis and Vedolizumab.
His Internal medicine study frequently draws connections between related disciplines such as Gastroenterology.
His Crohn's disease research is multidisciplinary, relying on both Young adult, Surgery, Cohort study and C-reactive protein.
The Inflammatory bowel disease study combines topics in areas such as Tumor necrosis factor alpha, Incidence, Epidemiology, Standardized mortality ratio and Proportional hazards model.
His Ulcerative colitis study combines topics in areas such as Odds ratio, Colon surgery, Long term safety and Colitis.
Edward V. Loftus interconnects Ustekinumab, Retrospective cohort study, Propensity score matching, Severity of illness and Cohort in the investigation of issues within Vedolizumab.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
